The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
by The Investment U Research Team
Almost four months ago we discussed E*Trade Financial (Nasdaq: ETFC) and it’s forgotten brokerage profit center. In the month afterwards to April 17, E*Trade climbed an impressive 248%.
That price has fallen by almost 50% since – and it’s just one of the reasons why we’re looking at E*Trade again. The larger basis behind our attention to ETFC is the short interest.
In March the short interest was 13% with 70 million shares being shorted. Currently it stands at 16% with over 90 million shares shorted.
Ultimately, E*Trade’s issues come back to the amount of non-performing mortgage debt it has on its balance sheets, how much it can refinance and how those losses will affect the rest of its income.
In the meantime, they’ve been raising capital and issuing new stock.
Until Wall Street feels comfortable with these items, they’ll be cautious. That means smaller investors have the ability to take advantage of this emotional seesaw and profit from E*Trade’s gyrations.
Who knows if we’ll see another 250% gain. But if the stock price moves back to its April highs, it would represent a 100% gain from today’s price of $1.25. Not bad by any stretch for a short-term gain.
Symbols mentioned in this article: ETFC.
- E*Trade Forgotten Profit Center
- E*Trade Financial (Nasdaq: ETFC): Why This Company’s Takeover Prospects Keep Improving
- E*Trade (Nasdaq: ETFC): Why You Should Buy This Stock Before It’s Too Late
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed